ArticleThe Lancet. Infectious diseases2018
Grading antimicrobial susceptibility data quality: room for improvement.
Article in The Lancet. Infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Gram-negative neonatal sepsis in low- and lower-middle-income countries and WHO empirical antibiotic recommendations: A systematic review and meta-analysis.PLoS medicine · 2021Pooled it
- Advancing AMR Surveillance: Confluence of One Health and Big Data Integration : Converging One Health and Big Data for AMR.EcoHealth · 2025Review
- Antimicrobial resistance among children in Southeast Asia: a systematic review.BMJ public health · 2025Article
- Transportability of bacterial infection prediction models for critically ill patients.Journal of the American Medical Informatics Association : JAMIA · 2023Article
- Estimating antibiotic coverage from linked microbiological and clinical data from the Swiss Paediatric Sepsis Study to support empiric antibiotic regimen selection.Frontiers in pediatrics · 2023Article
- Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture.Antimicrobial resistance and infection control · 2021Review
- Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries.Clinical microbiology reviews · 2020Review
- Microbiology Investigation Criteria for Reporting Objectively (MICRO): a framework for the reporting and interpretation of clinical microbiology data.BMC medicine · 2019Article
- Harnessing alternative sources of antimicrobial resistance data to support surveillance in low-resource settings.The Journal of antimicrobial chemotherapy · 2019Review
- Antimicrobial Resistance in the Asia Pacific region: a meeting report.Antimicrobial resistance and infection control · 2019Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
29856355What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.